WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004007484) FUMARATE SALTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/007484    International Application No.:    PCT/SE2003/001207
Publication Date: 22.01.2004 International Filing Date: 14.07.2003
Chapter 2 Demand Filed:    30.01.2004    
IPC:
C07D 311/24 (2006.01)
Applicants: ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje (SE) (For All Designated States Except US).
KIRSCHNER, Alan [US/US]; (US) (For US Only).
MCCABE, James [GB/GB]; (GB) (For US Only).
WILLIAMS, Emyr [GB/GB]; (GB) (For US Only).
YMEN, Ingvar [SE/SE]; (SE) (For US Only)
Inventors: KIRSCHNER, Alan; (US).
MCCABE, James; (GB).
WILLIAMS, Emyr; (GB).
YMEN, Ingvar; (SE)
Agent: GLOBAL INTELLECTUAL PROPERTY; AstraZeneca AB, S-151 85 Södertälje (SE)
Priority Data:
60/396,070 15.07.2002 US
Title (EN) FUMARATE SALTS
(FR) SELS DE FUMARATE
Abstract: front page image
(EN)The present invention relates to novel crystalline forms of 6-fluoro-8-(4-methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid [4-(4-propionyl-piperazin-1-yl)-phenyl]-amide fumarate salt. The present invention also relates to the use of said compounds for the treatment of depression, generalized anxiety, eating disorders, dementia, panic disorder, sleep disorders, gastrointestinal disorders, motor disorders, endocrine disorders, vasospasm, or sexual dysfunction, pharmaceutical compositions containing them and processes for obtaining them.
(FR)L'invention concerne de nouvelles formes cristallines de sel de fumarate de [4-(4-propionyl-pipérazin-1-yl)-phényl]-amide d'acide 6-fluoro-8-(4-méthyl-pipérazin-1-yl)-4-oxo-4H-chromène-2-carboxylique. L'invention concerne également l'utilisation desdits composés pour le traitement de la dépression, de l'anxiété généralisée, de troubles de l'alimentation, de démence, de trouble panique, de spasme vasculaire, ou de dysfonction sexuelle. L'invention concerne également des compositions pharmaceutiques contenant celles-ci et des méthodes permettant de les obtenir.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)